We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA's Regulation of Stem Cells and Regenerative Medicine in Light of Regenerative Sciences

01 April 20141:00 PM - 2:00 PM (EST)

Hogan Lovells recently hosted a 60-minute webinar on FDA's Regulation of Stem Cells and Regenerative Medicine in Light of Regenerative Sciences. The webinar took place on Tuesday, April 1, 2014 at 1:00 p.m. ET and covered the following topics:

  • Can stem cell therapies still be considered within the practice of medicine and outside the realm of FDA oversight?
  • The implications of Regenerative Sciences with respect to pre- and post-market oversight.
  • The effect of growing demand for stem cell treatments and the risks of medical tourism to countries with inadequate regulatory oversight.
  • Development models: practical pathways from research to profitability.

Download the Webinar Recording
Download Webinar Materials

01 April 2014
1:00 PM - 2:00 PM (EST)

Speaker list

Loading data